USDA-Approved FeLV, FIV Drug Available Online
Veterinarians may now order Lymphocyte T-Cell Immunomodulator (LTCI) -- reportedly the first United States Department of Agriculture (USDA) approved treatment for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) -- directly from the manufacturer, T-Cyte Therapeutics.
Veterinarians can order the product at the company website or by phone. The streamlined ordering process means practitioners and animal clinics can expedite treatment of FeLV and FIV.
“We’ve worked hard to build a process that streamlines access to the product, provides pertinent, practical and accurate information regarding the treatment of FeLV and FIV and gives veterinarians’ direct-source access to LTCI,” says Dr. Beardsley. “Ordering LTCI from T-Cyte will be efficient for veterinarians and can be a life-saver for sick pets. The site will also make it easier for pet owners to locate local veterinarians who have treated cats suffering from these diseases. The website will be a one-stop data source to aid in the treatment of FeLV and FIV.”
The site also features educational and product information about retroviral health care and a nationwide, searchable database of veterinary clinics that offer LTCI is in the works.
LTCI was briefly distributed by Imulan and most recently by AgriLabs, who successfully introduced and marketed LTCI to the veterinary profession. Visit Tcyte.com for product information and ordering, or call (800) 483-2104.